The Know AML website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know AML cannot guarantee the accuracy of translated content. Know AML and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
How does your genetic makeup affect how your acute myeloid leukemia is treated?
Agnieszka Wierzbowska
July 5, 2021
During the EHA2021 Virtual Congress, Know AML spoke with Agnieszka Wierzbowska, University of Lodz, Lodz, PL. We asked, How does your genetic makeup affect how your acute myeloid leukemia is treated? In this video, Wierzbowska discusses how your genetic makeup can affect the way you are treated, if you may relapse or achieve remission, and your long-term outcomes. She continues by describing the novel targeted therapies, which allow for a more personalized treatment approach.
To what extent do you agree with the following statements?
Please rate between 1 and 5, with 1 being 'strongly disagree' and 5 being 'strongly agree'.
